News

06 October 2010

The pathological complete response predicts a better prognosis in advanced rectal cancer

According to the study, among patients with locally advanced rectal cancer treated with a combination of chemotherapy and radiotherapy and subsequent surgery, the complete disappearance of detectable cancer cells (called pathologic complete response) after the treatment is related to better long-ter
30 September 2010

Proteins involved in bone metabolism are associated with breast cancer

RANK protein and its ligand RANKL (the molecule that allows the protein to perform its function) are involved in the formation of breast tumors, according to a study published this week in Nature.
27 September 2010

The regulation of cellular oxidation may play a key role in controlling liver cancer

The results indicate that Nox1 protein, a member of the NADPH oxidase family, controls the growth of tumour cells in the liver through regulation of the epidermal growth factor (EGF) receptor, which is involved in several processes altered in cancer cells such as growth, apoptosis (programmed cell d
08 August 2010

Researchers find a biomarker that predicts a good response to a new drug against breast cancer

A recent example in this field is the finding that patients with familial breast and ovarian cancer carrying mutations in the BRCA1 gene are more sensitive to drugs called inhibitors of PARP (poly-adenosine diphosphate ribose polymerase) protein.
28 July 2010

IDIBELL and the Association of Neurofibromatosis Patients sign an agreement